Skip to main content

PharmaTutor Magazine - April 2018 is released | Subscribe today

 

Clinical courses

 

Clinical research courses

Magazine Home


<< BACK TO LATEST ISSUES

PURCHASE ONLINE MAGAZINE >>

April 2018

 

CCRAS Developed a AYUSH Drug QOL-2C for Cancer Patients

The Central Council for Research in Ayurvedic Sciences (CCRAS) is an autonomous body of the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy), Government of India. It is an apex body in India for the formulation, coordination, development and promotion of research on scientific lines in Ayurveda and Sowa-Rigpa system of medicine.

Central Council for Research in Ayurvedic Sciences (CCRAS) has undertaken development of a coded drug AYUSH QOL-2C for improving the quality of life in cancer patients. The clinical studies were conducted at St. John’s Medical College, Bengaluru and AIIMS, New Delhi in breast cancer patients and at Bhagwan Mahaveer Cancer Hospital and Research Centre, Jaipur in lung cancer patients.

Cancer is the uncontrolled growth of abnormal cells anywhere in a body. These abnormal cells are termed cancer cells. These cells can infiltrate normal body tissues. Deaths from cancer worldwide are projected to continue rising, with an estimated 13.1 million deaths in 2030.

It is not possible to compare the expenditure on research on cancer in Ayurveda viz-à-viz Allopathy as it depends upon variables like methodology, parameters etc. adopted for research.

READ ONLINE | E-MAGAZINE

SUBSCRIBE FOR MAGAZINE

DOWNLOAD SCHOLARLY ARTICLES SEPARATELY